Focus: HawkCell is a specialized biotech company focused on MRI research technology for gastroenterology applications, operating at a mid-sized scale with 51-200 employees from Lyon, France.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
Stable — net -1 jobs in 30d
1 added, 2 removed. Backfill posture.
HawkCell offers a specialized technical opportunity in a focused niche, but the absence of clinical pipeline development and minimal hiring suggest this is better suited for early-stage researchers than mid-to-senior career builders seeking growth trajectory.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for HawkCell
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from HawkCell's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
A Veterinary DICOM-Based Deep Learning Denoising Algorithm Can Improve Subjective and Objective Brain MRI Image Quality.
Accelerating veterinary low field MRI acquisitions using the deep learning based denoising solution HawkAI.